Fulgent Genetics, Inc.
USD20.53
+0.57 (+2.86%)
CEO
Ming Hsieh
IPO Date
2016-09-29
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$19.77
Prev. Close
$19.96
Day Low
$19.77
Day High
$20.58
52W Low
$13.46
52W High
$31.04
Market Cap
$0.58B
Volume
0.29M
| $17.67 |
| 28 May 2026 | Gao Hanlin | Chief Scientific Officer | S-Sale | Disposed | 945 | $17.60 |
| 27 May 2026 | Hsieh Ming | director, 10 percent owner, officer: Chief Executive Officer | F-InKind | Disposed | 2,949 | $17.67 |
| 18 May 2026 | Nohaile Michael | director | A-Award | Acquired | 5,558 | $0.00 |
| 18 May 2026 | Nohaile Michael | director | A-Award | Acquired | 8,426 | $16.19 |
| 18 May 2026 | Dong Linda | director | A-Award | Acquired | 11,117 | $0.00 |
| 18 May 2026 | GROVES REGINA E | director | A-Award | Acquired | 11,117 | $0.00 |
| 28 Apr 2026 | Gao Hanlin | Chief Scientific Officer | F-InKind | Disposed | 1,645 | $16.31 |
| 28 Apr 2026 | Xie Jian | President and COO | F-InKind | Disposed | 4,361 | $16.31 |